Cover Image
市場調查報告書

NKT Therapeutics, Inc.:產品平台分析

NKT Therapeutics, Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 321973
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
NKT Therapeutics, Inc.:產品平台分析 NKT Therapeutics, Inc. - Product Pipeline Review - 2014
出版日期: 2014年12月24日 內容資訊: 英文 20 Pages
簡介

NKT Therapeutics, Inc. 是基於被稱為NKT細胞的免疫細胞來開發治療藥的生物科技企業。該公司正在開發鐮狀細胞貧血症,自體免疫疾病,發炎性疾病,癌症,氣喘,皮膚炎等治療藥。同時也在開發抗體治療藥。

本報告提供NKT Therapeutics, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

NKT Therapeutics, Inc.的基本資料

NKT Therapeutics, Inc.概要

  • 主要資訊
  • 企業資料

NKT Therapeutics, Inc.:R&D概要

  • 主要的治療範圍

NKT Therapeutics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

NKT Therapeutics, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

NKT Therapeutics, Inc.:藥物簡介

  • NKTT-120
  • iNKT mAb
  • NKTT-320

NKT Therapeutics, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

NKT Therapeutics, Inc.:最近的開發平台趨勢

NKT Therapeutics, Inc.:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06719CDB

Summary

Global Markets Direct's, 'NKT Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the NKT Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NKT Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of NKT Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of NKT Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the NKT Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate NKT Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of NKT Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the NKT Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of NKT Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of NKT Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of NKT Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • NKT Therapeutics, Inc. Snapshot
    • NKT Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • NKT Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • NKT Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • NKT Therapeutics, Inc. - Pipeline Products Glance
    • NKT Therapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • NKT Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • NKT Therapeutics, Inc. - Drug Profiles
    • NKTT-120
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • iNKT mAb
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NKTT-320
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • NKT Therapeutics, Inc. - Pipeline Analysis
    • NKT Therapeutics, Inc. - Pipeline Products by Route of Administration
    • NKT Therapeutics, Inc. - Pipeline Products by Molecule Type
  • NKT Therapeutics, Inc. - Recent Pipeline Updates
  • NKT Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • NKT Therapeutics, Inc., Key Information
  • NKT Therapeutics, Inc., Key Facts
  • NKT Therapeutics, Inc. - Pipeline by Indication, 2014
  • NKT Therapeutics, Inc. - Pipeline by Stage of Development, 2014
  • NKT Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014
  • NKT Therapeutics, Inc. - Phase I, 2014
  • NKT Therapeutics, Inc. - Preclinical, 2014
  • NKT Therapeutics, Inc. - Pipeline by Route of Administration, 2014
  • NKT Therapeutics, Inc. - Pipeline by Molecule Type, 2014
  • NKT Therapeutics, Inc. - Recent Pipeline Updates, 2014

List of Figures

  • NKT Therapeutics, Inc. - Pipeline by Top 10 Indication, 2014
  • NKT Therapeutics, Inc. - Pipeline by Stage of Development, 2014
  • NKT Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014
  • NKT Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2014
Back to Top